Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × esmolol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1

Interventions

Cyclophosphamide 765 Carboplatin 665 Paclitaxel 620 Bevacizumab 611 pembrolizumab 585 Cisplatin 574 Gemcitabine 520 Docetaxel 485 Rituximab 471 Radiotherapy 469 Dexamethasone 420 Nivolumab 395 Doxorubicin 377 Capecitabine 332 Fluorouracil 327 Etoposide 304 Cytarabine 281 Oxaliplatin 281 Pemetrexed 281 Lenalidomide 273 Prednisone 271 fludarabine phosphate 265 Erlotinib Hydrochloride 261 Leucovorin 255 fludarabine 253 Trastuzumab 248 Bortezomib 240 Vincristine 239 Filgrastim 236 Cetuximab 227

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01951950 2014-08-29

Nicardipine vs Esmolol Craniotomy Emergence

Northwestern University

Phase 1 Completed

40 enrolled 6 charts

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡